Summary - TAK - NYSE - Weiss Ratings

C

Takeda Pharmaceutical Company Limited TAK

$15.03 -$0.08-0.53% NYSE

Recommendation

Prev Close

Volume

Avg Vol (90D)

Market Cap

Dividend & Yield

52-Week Range

$12.58 - $15.37

P/E (TTM)

EPS (TTM)

My Lists My Alerts

Access our Premium Ratings

Get Access

Rating

Reward

Risk

Rating Factors

Growth Index

Efficiency Index

Solvency Index

Total Return Index

Volatility Index

Dividend Index

Headlines

Exelixis' Q1 Earnings: Will Cabometyx Maintain Momentum?

4/25/2025 - Zacks Investment Research

Sterling Capital Management LLC Cuts Stock Position in Takeda Pharmaceutical Company Limited (NYSE:TAK)

4/23/2025 - MarketBeat

Are Investors Undervaluing Takeda Pharmaceutical Co. (TAK) Right Now?

4/21/2025 - Zacks Investment Research

Forum Financial Management LP Acquires 65,399 Shares of Takeda Pharmaceutical Company Limited (NYSE:TAK)

4/21/2025 - MarketBeat

These States Are Driving 21st Century Technology Faster Than the Rest

4/19/2025 - 24/7 Wall St.

Wells Fargo & Company MN Has $11.44 Million Position in Takeda Pharmaceutical Company Limited (NYSE:TAK)

4/17/2025 - MarketBeat

TAK vs. DSNKY: Which Stock Is the Better Value Option?

4/16/2025 - Zacks Investment Research

Causeway Capital Management LLC Sells 759,162 Shares of Takeda Pharmaceutical Company Limited (NYSE:TAK)

4/16/2025 - MarketBeat

Takeda Completes Significant Share Repurchase in March 2025

4/14/2025 - TipRanks Financial Blog

Takeda Pharmaceutical Company Limited (NYSE:TAK) Stock Holdings Decreased by Federated Hermes Inc.

4/14/2025 - MarketBeat

Takeda Pharmaceutical Co Ltd (TAK) Shares Gap Down to $13.745 on Apr 10

4/10/2025 - GuruFocus

The volume for Takeda Pharmaceutical stock increased for three consecutive days, resulting in a record-breaking daily growth of 145% of the 65-Day Volume Moving Average

4/10/2025 - Tickeron - Stocks

The volume for Takeda Pharmaceutical stock increased for one day, resulting in a record-breaking daily growth of 206% of the 65-Day Volume Moving Average

4/8/2025 - Tickeron - Stocks

BioInvent Receives Milestone Payment as Takeda moves mezagitamab into Phase 3

4/8/2025 - Accesswire

Takeda Pharmaceutical Co Ltd (TAK) Stock Price Down 3.78% on Apr 7

4/7/2025 - GuruFocus

Takeda Pharmaceutical (NYSE:TAK) Sets New 1-Year High - Should You Buy?

4/5/2025 - MarketBeat

Is Takeda Pharmaceutical Co. (TAK) Stock Undervalued Right Now?

4/4/2025 - Zacks Investment Research

Takeda Pharmaceutical (NYSE:TAK) Rating Increased to Overweight at Morgan Stanley

4/4/2025 - MarketBeat

European, Asian pharma stocks rally as Trump spares sector from reciprocal tariffs but the cheer may be shortlived

4/3/2025 - Invezz News

Raymond James Financial Inc. Invests $1.45 Million in Takeda Pharmaceutical Company Limited (NYSE:TAK)

4/3/2025 - MarketBeat

TAK vs. DSNKY: Which Stock Should Value Investors Buy Now?

3/31/2025 - Zacks Investment Research

Takeda Pharmaceutical Co. Ltd. Buys Shares of 203,190 Rani Therapeutics Holdings, Inc. (NASDAQ:RANI)

3/28/2025 - MarketBeat

Takeda Pharmaceutical Co. Ltd. Acquires Shares of 823,317 Lyell Immunopharma, Inc. (NASDAQ:LYEL)

3/28/2025 - MarketBeat

Takeda Pharmaceutical Co. Ltd. Makes New Investment in Shattuck Labs, Inc. (NASDAQ:STTK)

3/28/2025 - MarketBeat

77,733 Shares in American Well Co. (NYSE:AMWL) Purchased by Takeda Pharmaceutical Co. Ltd.

3/28/2025 - MarketBeat

Income Statement

Total Revenue (TTM)

EBITDA (TTM)

EBIT (TTM)

Net Income (TTM)

Balance Sheet

Total Assets (Q)

Total Debt (Q)

Total Liabilities (Q)

Book Value Per Share (Q)

Cash Flow

Cash from Operations (TTM)

Cash from Investing (TTM)

Cash from Financing (TTM)

Net Change in Cash (TTM)

Filings

Filing Date

Thursday, January 30, 2025

Period Date

Tuesday, December 31, 2024

Next Filing

Week of Jun 23 and 27 (est)

Price History

Loading...

Beta

7-Day Total Return

30-Day Total Return

60-Day Total Return

90-Day Total Return

Year to Date Total Return

1-Year Total Return

2-Year Total Return

3-Year Total Return

5-Year Total Return

52-week Low

Jun 20, 2024 - $12.58

52-week High

Apr 03, 2025 - $15.37

Valuation

Market Cap

$45.60B - Large Cap

Enterprise Value

Price/Sales (TTM)

Price/Book (Q)

Dividends and Shares

Shares Outstanding

Dividend Per Share (Most Recent)

Dividend Per Share (TTM)

Corporate Info

Website

Phone Number

81 3 3278-2111

Address

1-1, Nihonbashi-Honcho 2-chome
Tokyo, 103-8668

Country

Year Founded

Business Description

Sector

--

Industry

--

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers... more